WallStreetZenWallStreetZen

NYSE: COR
Cencora Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

COR past earnings growth

How has COR's earnings growth performed historically?
Company
17.26%
Industry
9.57%
Market
114.07%
COR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
COR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
COR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

COR past revenue growth

How has COR's revenue growth performed historically?
Company
11.71%
Industry
9.9%
Market
17.3%
COR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
COR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
COR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

COR earnings and revenue history

Current Revenue
$276.5B
Current Earnings
$1.9B
Current Profit Margin
0.7%
COR's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

COR Return on Equity

Current Company
231.3%
Current Industry
123.4%
Current Market
28.2%
COR's Return on Equity (231.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when COR announces earnings.

COR Return on Assets

Current Company
2.9%
Current Industry
2.4%
COR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

COR Return on Capital Employed

Current Company
17.93%
Current Industry
14.1%
COR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

COR vs Medical Distribution Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
COR$276.54B$2.97B$1.85B+9.56%+16.32%
CAH$220.57B$1.70B$552.00M+8.97%+66.16%
MCK$301.51B$4.53B$3.00B+7.15%+58.70%
HSIC$12.45B$873.00M$388.00M+5.55%-2.13%
PDCO$6.57B$384.69M$193.86M+3.46%+19.70%
View Top Medical Distribution Stocks

Cencora Earnings & Revenue FAQ

What were COR's earnings last quarter?

On Invalid Date, Cencora (NYSE: COR) reported Q1 2024 earnings per share (EPS) of $2.11, up 1.86% year over year. Total Cencora earnings for the quarter were $420.78 million. In the same quarter last year, Cencora's earnings per share (EPS) was $2.15.

If you're new to stock investing, here's how to buy Cencora stock.

What was COR's earnings growth in the past year?

As of Q2 2024, Cencora's earnings has grown 17.26% year over year. This is 7.69 percentage points higher than the US Medical Distribution industry earnings growth rate of 9.57%. Cencora's earnings in the past year totalled $1.85 billion.

What was COR's revenue last quarter?

On Invalid Date, Cencora (NYSE: COR) reported Q1 2024 revenue of $68.41 billion up 7.81% year over year. In the same quarter last year, Cencora's revenue was $63.46 billion.

What was COR's revenue growth in the past year?

As of Q2 2024, Cencora's revenue has grown 11.71% year over year. This is 1.81 percentage points higher than the US Medical Distribution industry revenue growth rate of 9.9%. Cencora's revenue in the past year totalled $276.54 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.